Skip to main content
Top
Metadata
Title
Asthma and risk of lung cancer
Authors
María Teresa García Sanz
Francisco Javier González Barcala
José Manuel Álvarez Dobaño
Luis Valdés Cuadrado
Publication date
01-10-2011
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 10/2011
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-011-0723-9

Other articles of this Issue 10/2011

Clinical and Translational Oncology 10/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine